The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice
The influence of an anti-allergic agent, suplatast tosilate (IPD-1151T; (±)-[2-[4-(3-ethoxy–2-hydroxypropoxy)phenyl-carbamoyl]-ethyl] dimethylsulfonium p-toluenesulfonate) on allergic bronchoconstriction induced by allergen and methacholine (MCh) were examined in mice. BALB/c mice were sensitized by...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2000-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/096293500411532 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832565208112955392 |
---|---|
author | Kazuhito Asano Tetsuya Mizutani Toshikazu Shimane Masataka Hisano Tadashi Hisamitsu Harumi Suzaki |
author_facet | Kazuhito Asano Tetsuya Mizutani Toshikazu Shimane Masataka Hisano Tadashi Hisamitsu Harumi Suzaki |
author_sort | Kazuhito Asano |
collection | DOAJ |
description | The influence of an anti-allergic agent, suplatast tosilate (IPD-1151T; (±)-[2-[4-(3-ethoxy–2-hydroxypropoxy)phenyl-carbamoyl]-ethyl] dimethylsulfonium p-toluenesulfonate) on allergic bronchoconstriction induced by allergen and methacholine (MCh) were examined in mice. BALB/c mice were sensitized by intraperitoneal injection of dinitrophenylated-keyhole limpet hemocyanin (DNP-KLH) mixed with
Al(OH)3 (DNP-KLH). IPD-1151T was administered orally once a day for either 5 or 14 days in doses of 10, 30 or 100 mg/kg. Bronchoconstriction was measured 24 h after the final drug administration. IPD-1151T inhibited both antigen- and MCh-mediated bronchoconstriction in actively sensitized mice. The inhibition induced was closely related to the dose and frequency of oral administration of the agent. We also examined the effect of IPD-1151T on IgE production in response to DNP-KLH immunization. IPD-1151T inhibited dose-dependently both total and specific IgE concentrations in serum prepared from mice 15 days after im munization. These results strongly indicate that IPD-1151T inhibits IgE
production in vivo and results in attenuating effect on bronchoconstriction. |
format | Article |
id | doaj-art-ed8bd14e565a4eee9d91de52ef6cf6ea |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2000-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-ed8bd14e565a4eee9d91de52ef6cf6ea2025-02-03T01:09:03ZengWileyMediators of Inflammation0962-93511466-18612000-01-0192778410.1080/096293500411532The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized miceKazuhito Asano0Tetsuya Mizutani1Toshikazu Shimane2Masataka Hisano3Tadashi Hisamitsu4Harumi Suzaki5Department of Physiology, School of Medicine, Showa University, Shinagawa-ku, Tokyo 142–8555, JapanDepartment of Otolaryngology, School of Medicine, Showa University, Shinagawa-ku, Tokyo 142–8555, JapanDepartment of Otolaryngology, School of Medicine, Showa University, Shinagawa-ku, Tokyo 142–8555, JapanDepartment of Physiology, School of Medicine, Showa University, Shinagawa-ku, Tokyo 142–8555, JapanDepartment of Physiology, School of Medicine, Showa University, Shinagawa-ku, Tokyo 142–8555, JapanDepartment of Otolaryngology, School of Medicine, Showa University, Shinagawa-ku, Tokyo 142–8555, JapanThe influence of an anti-allergic agent, suplatast tosilate (IPD-1151T; (±)-[2-[4-(3-ethoxy–2-hydroxypropoxy)phenyl-carbamoyl]-ethyl] dimethylsulfonium p-toluenesulfonate) on allergic bronchoconstriction induced by allergen and methacholine (MCh) were examined in mice. BALB/c mice were sensitized by intraperitoneal injection of dinitrophenylated-keyhole limpet hemocyanin (DNP-KLH) mixed with Al(OH)3 (DNP-KLH). IPD-1151T was administered orally once a day for either 5 or 14 days in doses of 10, 30 or 100 mg/kg. Bronchoconstriction was measured 24 h after the final drug administration. IPD-1151T inhibited both antigen- and MCh-mediated bronchoconstriction in actively sensitized mice. The inhibition induced was closely related to the dose and frequency of oral administration of the agent. We also examined the effect of IPD-1151T on IgE production in response to DNP-KLH immunization. IPD-1151T inhibited dose-dependently both total and specific IgE concentrations in serum prepared from mice 15 days after im munization. These results strongly indicate that IPD-1151T inhibits IgE production in vivo and results in attenuating effect on bronchoconstriction.http://dx.doi.org/10.1080/096293500411532 |
spellingShingle | Kazuhito Asano Tetsuya Mizutani Toshikazu Shimane Masataka Hisano Tadashi Hisamitsu Harumi Suzaki The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice Mediators of Inflammation |
title | The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice |
title_full | The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice |
title_fullStr | The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice |
title_full_unstemmed | The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice |
title_short | The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice |
title_sort | inhibitory effect of anti allergic agent suplatast tosilate ipd 1151t on methacholine and allergen induced bronchoconstriction in sensitized mice |
url | http://dx.doi.org/10.1080/096293500411532 |
work_keys_str_mv | AT kazuhitoasano theinhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice AT tetsuyamizutani theinhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice AT toshikazushimane theinhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice AT masatakahisano theinhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice AT tadashihisamitsu theinhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice AT harumisuzaki theinhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice AT kazuhitoasano inhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice AT tetsuyamizutani inhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice AT toshikazushimane inhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice AT masatakahisano inhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice AT tadashihisamitsu inhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice AT harumisuzaki inhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice |